At its meeting on June 23, 2020, the Board approved $25 million to fund 10 new studies comparing the most effective ways to treat a range of health conditions that impose high burdens on patients, their families, and the health care system. Among the new projects receiving PCORI funding support are
- a California-based study examining strategies for improving care for people recovering from cancer surgery,
- a Minnesota-based study comparing two strategies for monitoring blood glucose for people with Type 2 diabetes who are insulin dependent, and
- a Tennessee-based study that compares the addition of a culturally tailored counseling strategy to see if it is more effective in improving diabetes-related outcomes among African-American women.
The Board also approved a Texas-based Implementation project on blood clot prevention, as well as up to $30 million for a new funding opportunity opening in September for research focused on interventions to prevent youth suicide. Finally, the Board approved up to $50 million in additional funding for COVID-19-related research.
PCORI's Response to COVID-19
- PCORI’s COVID-19 Updates
- HERO Registry and Trial
- Funding Opportunities for COVID-19 Enhancements to Existing PCORI-Funded Projects
- COVID-19 Targeted PFA (For innovative, high-impact comparative clinical effectiveness research)
PCORI Funding Announcements Relating to the New Awards
- Broad PCORI Funding Announcements -- Cycle 3 2019
- Implementation of PCORI-Funded Patient-Centered Outcomes Research Results -- Cycle 3 2019
All PCORI Board meetings are open to the public. This meeting was held via teleconference/webinar with no public comment period.
Catch up on past PCORI Board meetings here.